← Back to Search

Cannabinoid

Cannabigerol for Rheumatoid Arthritis

N/A
Waitlist Available
Research Sponsored by Raphael Pharma
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
* Male or female, over 25 years of age
* Active RA-related inflammation with at least 2 swollen joints
Timeline
Screening 3 weeks
Treatment Varies
Follow Up baseline, week 2, week 4, week 6, and week 8
Awards & highlights
No Placebo-Only Group

Summary

This trial aims to see how effective purified cannabigerol (CBG) is in treating rheumatoid arthritis in patients over 8 weeks. They will use lab tests and patient-reported outcomes to

Who is the study for?
This trial is for adults over 25 with active rheumatoid arthritis, evidenced by at least two swollen joints and a positive anti-CCP blood test. Participants must be university graduates, generally healthy without uncontrolled chronic diseases, live in the USA, and agree to follow study rules including avoiding other cannabis products.
What is being tested?
The trial is testing the effectiveness of Cannabigerol (CBG) on patients with active rheumatoid arthritis over an 8-week period. It's a single-group study where all participants receive CBG and their responses are measured through lab tests and self-reports.
What are the potential side effects?
Potential side effects of CBG may include dry mouth, light-headedness, drowsiness, changes in appetite or mood. Since this is an exploratory study specific side effects related to long-term use in RA patients will be closely monitored.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
I am over 25 years old.
Select...
I have active rheumatoid arthritis with at least 2 swollen joints.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~baseline, week 2, week 4, week 6, and week 8
This trial's timeline: 3 weeks for screening, Varies for treatment, and baseline, week 2, week 4, week 6, and week 8 for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Change in inflammatory markers from Baseline to Week 8
Secondary study objectives
Change in self-reported symptoms and quality of life from Baseline to Week 8

Awards & Highlights

No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.

Trial Design

1Treatment groups
Experimental Treatment
Group I: CBG TreatmentExperimental Treatment1 Intervention
Participants will receive 0.5 milliliters of purified cannabigerol (CBG) in sesame oil once daily in the evening for a duration of eight weeks.

Find a Location

Who is running the clinical trial?

Raphael PharmaLead Sponsor
CitruslabsIndustry Sponsor
91 Previous Clinical Trials
4,858 Total Patients Enrolled
~0 spots leftby Dec 2024
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top